Filing Details
- Accession Number:
- 0001140361-12-045707
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-11-05 19:54:21
- Reporting Period:
- 2012-11-01
- Filing Date:
- 2012-11-05
- Accepted Time:
- 2012-11-05 19:54:21
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
943819 | Resmed Inc | RMD | Surgical & Medical Instruments & Apparatus (3841) | 980152841 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1485164 | J. Michael Farrell | Resmed Inc. 9001 Spectrum Center Blvd San Diego CA 92123 | President - Americas | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Resmed Common Stock | Acquisiton | 2012-11-01 | 20,000 | $21.71 | 119,300 | No | 4 | M | Direct | |
Resmed Common Stock | Disposition | 2012-11-01 | 20,000 | $40.80 | 99,300 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Resmed Common Stock | ResMed Common Stock Options | Disposition | 2012-11-01 | 20,000 | $0.00 | 20,000 | $21.71 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2008-08-01 | 2014-08-01 | No | 4 | M | Direct |
Footnotes
- Represents date options first became exercisable. Options vest 1/4 each year on the anniversary of the grant.
- Includes 175.004 shares purchased on October 31, 2012, through the company Employee Stock Purchase Plan.
- This transaction was executed in multiple trades at prices ranging from $40.74-$40.82. The price reported reflects the weighted average sale price. The reporting person will provide full information regarding the number of shares and prices at which the transactin was effected upon request to the SEC staff, the issuer or the security holder of the issuer.